273 related articles for article (PubMed ID: 28386999)
1. Psoriatic cutaneous inflammation promotes human monocyte differentiation into active osteoclasts, facilitating bone damage.
Raimondo A; Lembo S; Di Caprio R; Donnarumma G; Monfrecola G; Balato N; Ayala F; Balato A
Eur J Immunol; 2017 Jun; 47(6):1062-1074. PubMed ID: 28386999
[TBL] [Abstract][Full Text] [Related]
2. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions.
Xue Y; Jiang L; Cheng Q; Chen H; Yu Y; Lin Y; Yang X; Kong N; Zhu X; Xu X; Wan W; Zou H
PLoS One; 2012; 7(10):e46740. PubMed ID: 23144698
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.
Ritchlin CT; Haas-Smith SA; Li P; Hicks DG; Schwarz EM
J Clin Invest; 2003 Mar; 111(6):821-31. PubMed ID: 12639988
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis.
Colucci S; Brunetti G; Cantatore FP; Oranger A; Mori G; Quarta L; Cirulli N; Mancini L; Corrado A; Grassi FR; Grano M
J Pathol; 2007 May; 212(1):47-55. PubMed ID: 17370327
[TBL] [Abstract][Full Text] [Related]
5. Sera of patients with axial spondyloarthritis (axSpA) enhance osteoclastogenic potential of monocytes isolated from healthy individuals.
Korkosz M; Czepiel M; Guła Z; Stec M; Węglarczyk K; Rutkowska-Zapała M; Gruca A; Lenart M; Baran J; Gąsowski J; Błyszczuk P; Siedlar M
BMC Musculoskelet Disord; 2018 Dec; 19(1):434. PubMed ID: 30522483
[TBL] [Abstract][Full Text] [Related]
6. Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion.
Dalbeth N; Pool B; Smith T; Callon KE; Lobo M; Taylor WJ; Jones PB; Cornish J; McQueen FM
Arthritis Res Ther; 2010; 12(4):R164. PubMed ID: 20796300
[TBL] [Abstract][Full Text] [Related]
7. Characterization and Function of Tumor Necrosis Factor and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis.
Yokota K; Sato K; Miyazaki T; Aizaki Y; Tanaka S; Sekikawa M; Kozu N; Kadono Y; Oda H; Mimura T
Arthritis Rheumatol; 2021 Jul; 73(7):1145-1154. PubMed ID: 33512089
[TBL] [Abstract][Full Text] [Related]
8. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
Liu C; Yang Y; Sun D; Wang C; Wang H; Jia S; Liu L; Lin N
Rejuvenation Res; 2015 Dec; 18(6):528-42. PubMed ID: 26418168
[TBL] [Abstract][Full Text] [Related]
9. Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.
Garimella MG; Kour S; Piprode V; Mittal M; Kumar A; Rani L; Pote ST; Mishra GC; Chattopadhyay N; Wani MR
J Immunol; 2015 Dec; 195(11):5136-48. PubMed ID: 26538398
[TBL] [Abstract][Full Text] [Related]
10. Focal bone involvement in inflammatory arthritis: the role of IL17.
Rossini M; Viapiana O; Adami S; Idolazzi L; Fracassi E; Gatti D
Rheumatol Int; 2016 Apr; 36(4):469-82. PubMed ID: 26521079
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis.
Polzer K; Neubert K; Meister S; Frey B; Baum W; Distler JH; Gückel E; Schett G; Voll RE; Zwerina J
Arthritis Rheum; 2011 Mar; 63(3):670-80. PubMed ID: 21360496
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of psoriatic arthritis and osteoclast differentiation.
Lembo C; Raimondo A; de Paulis A; Mormile I; Rossi FW; Lembo S; Balato A
Exp Dermatol; 2021 Dec; 30(12):1834-1837. PubMed ID: 34192381
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes.
Miranda-Carús ME; Benito-Miguel M; Balsa A; Cobo-Ibáñez T; Pérez de Ayala C; Pascual-Salcedo D; Martín-Mola E
Arthritis Rheum; 2006 Apr; 54(4):1151-64. PubMed ID: 16575870
[TBL] [Abstract][Full Text] [Related]
14. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
15. Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes.
Kim YG; Lee CK; Oh JS; Kim SH; Kim KA; Yoo B
Arthritis Rheum; 2010 Feb; 62(2):515-23. PubMed ID: 20112365
[TBL] [Abstract][Full Text] [Related]
16. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY
Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344
[TBL] [Abstract][Full Text] [Related]
17. Rheumatic diseases: the effects of inflammation on bone.
Walsh NC; Crotti TN; Goldring SR; Gravallese EM
Immunol Rev; 2005 Dec; 208():228-51. PubMed ID: 16313352
[TBL] [Abstract][Full Text] [Related]
18. Osteoclastogenesis and arthritis.
Maruotti N; Grano M; Colucci S; d'Onofrio F; Cantatore FP
Clin Exp Med; 2011 Sep; 11(3):137-45. PubMed ID: 21069419
[TBL] [Abstract][Full Text] [Related]
19. Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions.
Paine A; Ritchlin C
Calcif Tissue Int; 2018 May; 102(5):559-574. PubMed ID: 29330560
[TBL] [Abstract][Full Text] [Related]
20. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
